相关产品推荐更多 >

FASLG抗体FASLG兔多抗抗体Tumor necrosis factor ligand superfamily member 6 antibody抗体FASLG Antibody抗体
¥440
TEK抗体TEK一抗抗体VMCM1 antibody抗体Phospho-TEK (Y1102) Antibody抗体
¥880
CNMD抗体CNMD兔多抗抗体MYETS1 antibody抗体CNMD Antibody抗体
¥440
FGGY抗体FGGY兔多抗抗体EC 2.7.1.- antibody抗体FGGY Antibody抗体
¥440
NEK5抗体NEK5兔多抗抗体NimA-related protein kinase 5 antibody抗体NEK5 Antibody, HRP conjugated抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human Protein phosphatase 1 regulatory subunit 3A protein (900-1080AA)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
Non-conjugated
- 适应物种:
Human
- 保质期:
6个月
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
Q16821
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA, IHC; Recommended dilution: IHC:1:20-1:200
- 浓度:
>95%,Antigen Affinity Purified
- 靶点:
PPP1R3A
- 抗体英文名:
PPP1R3A Antibody
- 抗体名:
Type 1 protein phosphatase skeletal muscle glycogen targeting subunit antibody
- 规格:
100μl/50μl/20μl
| 规格: | 100μl | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μl | 产品价格: | ¥880.0 |
| 规格: | 20μl | 产品价格: | ¥440.0 |
保存缓冲液
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.功能
Seems to act as a glycogen-targeting subunit for PP1. PP1 is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Plays an important role in glycogen synthesis but is not essential for insulin activation of glycogen synthase (By similarity).风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Nucleic Acid Programmable Protein Arrays: Versatile Tools for Array‐Based Functional Protein Studies
‐88. Ernst, V., Levin, D.H., Foulkes, J.G., and London, I.M. 1982. Effects of skeletal muscle protein phosphatase inhibitor‐2 on protein synthesis and protein
v468. chapter 4 WNT 细胞通路 检测细胞GSK3活性与表达水平
., and Cohen, P. (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519–527. 6. Cohen, P. and Goedert, M. (2004) GSK3 inhibitors: development
from, or around a second bone, depending on the type of muscle contraction and the type of joint involved. Abnormal metabolism in the muscle may result in inappropriate contractility. For example, when stored glycogen or lipids cannot be used because of the lack
技术资料暂无技术资料 索取技术资料






